PI disease refers to primary immunodeficiency, a group of more than 400 conditions in which the immune system doesn’t work correctly. Unlike immune problems caused by medications or other illnesses, PI is genetic. You’re born with it, though symptoms can appear at any age and may worsen over time. An estimated 1 to 2% of the population has some form of PI, but many cases go undiagnosed because the symptoms, mainly frequent or unusual infections, overlap with common illnesses.
It’s worth noting that “Pi” also appears in medical shorthand for alpha-1 antitrypsin deficiency, a genetic lung and liver condition. If you’re looking for information on that disease, the section at the end of this article covers it briefly.
How PI Differs From Other Immune Problems
Immune deficiencies fall into two broad categories. Primary immunodeficiency is predetermined at birth by genetic changes that affect how immune cells develop or function. You may inherit the faulty gene from one or both parents, or the mutation may occur spontaneously. Secondary immunodeficiency, by contrast, is acquired. It develops as a side effect of chemotherapy, long-term steroid use, HIV infection, or other external factors that suppress the immune system. The distinction matters because PI typically requires lifelong management, while secondary immune deficiency sometimes resolves when the underlying cause is treated.
Common Types of PI
The 400-plus forms of PI range from mild to life-threatening. A few of the most recognized include:
- Common variable immunodeficiency (CVID): the most frequently diagnosed serious PI in adults. The body produces too few antibodies, leading to repeated respiratory and gastrointestinal infections.
- Selective IgA deficiency: the most common PI overall. Many people with it have no symptoms at all, while others experience sinus and lung infections or digestive issues.
- Severe combined immunodeficiency (SCID): sometimes called “bubble boy disease.” Infants with SCID have virtually no functioning immune system and can develop fatal infections within months if untreated.
- X-linked agammaglobulinemia (XLA): primarily affects boys and results in extremely low antibody levels, causing recurrent bacterial infections starting in early childhood.
Warning Signs to Recognize
The Jeffrey Modell Foundation developed a widely used checklist of 10 warning signs that suggest PI. No single sign is definitive on its own, but the presence of two or more is considered a reason to pursue testing:
- Four or more new ear infections in a year
- Two or more serious sinus infections in a year
- Two or more pneumonias in a year
- Two or more months on antibiotics with little improvement
- Needing intravenous antibiotics to clear an infection
- Two or more deep-seated infections such as bloodstream infections
- Recurrent deep skin or organ abscesses
- Persistent oral thrush or fungal skin infections
- Failure of an infant to gain weight or grow normally
- A family history of PI
Adults with PI often describe years of being told their frequent infections were “just bad luck” before finally getting a diagnosis. The average diagnostic delay can stretch well beyond a decade for milder forms like CVID.
How PI Is Diagnosed
The first step is usually a blood test measuring levels of the major antibody types: IgG, IgA, IgM, and IgE. Results are compared against age-matched normal ranges, since healthy antibody levels differ significantly between a toddler and an adult. If total antibody levels look normal but symptoms persist, doctors may test IgG subclasses or check for a specific type of natural antibody directed against blood group proteins, which serves as a quick indicator of whether the immune system is producing functional antibodies at all.
When antibody testing doesn’t explain the picture, further evaluation looks at the number and function of different immune cell types. Genetic testing can pinpoint the exact mutation responsible, which helps guide treatment and predict how the disease will progress. For newborns, some states now include SCID screening in their standard newborn blood spot tests, catching the most severe forms before infections set in.
Treatment and Daily Management
The cornerstone treatment for most antibody-deficient forms of PI is immunoglobulin replacement therapy, which supplies the antibodies the body can’t make on its own. This treatment comes in two forms, and the choice between them often comes down to lifestyle preference.
Intravenous infusions are given every three to four weeks. Each session takes several hours and is typically done at a hospital, infusion center, or at home with nurse supervision. Antibody levels peak right after the infusion, then gradually decline until the next one.
Subcutaneous infusions are self-administered at home, usually weekly or biweekly, using a small needle inserted just under the skin. Each session is shorter, and because the doses are smaller and more frequent, antibody levels stay more stable without the peaks and valleys of intravenous treatment. Many patients prefer this option because it fits more easily into a normal routine and doesn’t require medical supervision.
Both approaches reduce infection rates dramatically, but neither cures PI. Most people remain on replacement therapy for life.
When a Cure Is Possible
For SCID and a handful of other severe forms, a stem cell transplant can rebuild the immune system entirely. Outcomes depend heavily on timing. Infants transplanted before 3.5 months of age, before they’ve had a chance to contract serious infections, have survival rates of 80 to 95% regardless of donor type. Five-year overall survival has improved to better than 90% under optimal conditions, up from 56% for patients treated before 1995. The key factor is avoiding infection before the transplant: even older infants do very well if they reach transplant infection-free.
Autoimmune Complications
Counterintuitively, a weakened immune system doesn’t just underperform. It also misfires. Many people with PI develop autoimmune conditions in which the immune system attacks the body’s own tissues. In CVID, this commonly shows up as the immune system destroying red blood cells or platelets, or as inflammatory bowel disease, thyroid problems, or arthritis. Selective IgA deficiency is strongly linked to celiac disease. Complement deficiencies, which involve a different branch of the immune system, are associated with lupus-like symptoms.
These autoimmune problems sometimes appear before the PI itself is diagnosed, which can actually be the clue that leads doctors to check immune function in the first place. Managing PI-related autoimmunity is a balancing act, since many autoimmune treatments further suppress the immune system.
Alpha-1 Antitrypsin Deficiency: The Other “Pi Disease”
If your search was about alpha-1 antitrypsin deficiency, this is a separate genetic condition that uses “Pi” (protease inhibitor) notation to describe its genetic variants. The normal variant is called Pi*M. The most clinically significant variants are Pi*S (which produces moderately low levels of a protective lung protein) and Pi*Z (which produces very little). People who inherit two Z copies, written as Pi*ZZ, are at highest risk.
Alpha-1 antitrypsin deficiency primarily damages the lungs and liver. Lung symptoms typically begin between ages 25 and 50, starting with shortness of breath during mild activity, reduced exercise tolerance, and wheezing. Over time, many affected individuals develop emphysema. Other common symptoms include recurring respiratory infections, fatigue, unintentional weight loss, and a characteristic barrel-shaped chest as the disease progresses.